Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1746 participants.
Also called NCT01586910
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,746 participants
- Sponsor
- Registry
-
NCT01586910
-
- Other papers using this trial's data
- Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial
- Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial
- Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients
- Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients
- The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve Replacement
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Canada, Denmark, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT01586910. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2018-07 (actual). Results posted on 2019-09-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Acronym
- SURTAVI
- Condition
- Severe Aortic Stenosis
- Intervention (Device)
- Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
- Intervention (Procedure)
- Surgical Aortic Valve Replacement (SAVR)
- Intervention (Device)
- Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct01586910- Content hash
3e2d29f411d9caf9c0e940f324b9ff09727707b886088222ce88bcd096cac852